Deciphering the Antiviral Role of the L(2)EFL Gene Family in Dengue Virus Infection of Aedes aegypti

Deciphering the Antiviral Role of the L(2)EFL Gene Family in Dengue Virus Infection of Aedes aegypti

Literature Information

Research Background

Dengue fever, an acute infectious disease caused by Dengue Virus (DENV), poses a growing global public health threat, with Aedes aegypti serving as its primary transmission vector. The interaction between the mosquito’s host genes and DENV directly influences viral replication, transmission efficiency, and disease spread. Therefore, identifying mosquito genes that modulate DENV infection is critical for developing novel dengue control strategies.

The L(2)EFL gene family encodes proteins belonging to the small Heat Shock Protein 20 (HSP20) superfamily, which are known for their molecular chaperone, antioxidant, and anti-apoptotic activities. Emerging evidence links HSP20 proteins to viral infection processes, but the specific role of the L(2)EFL gene family in regulating DENV replication in Ae. aegypti remained poorly understood prior to this study. Addressing this knowledge gap could unlock new targets for interfering with dengue transmission.

Research Approach

The study adopted a systematic, multi-step approach to elucidate the role of the L(2)EFL gene family in DENV-2 infection:

  1. Differential Gene Expression Profiling: Utilize deep RNA sequencing to compare transcriptomic changes between DENV-2-infected and uninfected Ae. aegypti mosquitoes 14 days post-infection, identifying genes with significant expression alterations.
  2. Expression Validation: Confirm the differential expression of the L(2)EFL gene using real-time quantitative PCR (qPCR) for transcriptional analysis and Western Blot for protein level verification.
  3. Functional Validation:
    • Induce L(2)EFL overexpression via polyinosinic-polycytidylic acid (poly(I:C)) treatment and assess its impact on DENV-2 replication in Ae. aegypti-derived cell lines.
    • Suppress L(2)EFL expression using RNA interference (RNAi) with gene-specific double-stranded RNA (dsRNA) and evaluate changes in viral replication.
  4. Mechanistic Exploration: Investigate whether L (2) EFL modulates the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α)—a key regulator of protein translation and viral replication—to uncover potential signaling pathways.

Research Results

  1. Transcriptomic Analysis Identifies L(2)EFL Upregulation: Deep sequencing revealed that the L(2)EFL gene was significantly upregulated in DENV-2-infected Ae. aegypti compared to uninfected controls 14 days post-infection, with transcript abundance increased several-fold.
  2. Expression Validation Confirms Differential Regulation: qPCR and Western Blot experiments independently validated the upregulation of L(2)EFL at both transcriptional and protein levels, confirming the reliability of the sequencing data.
  3. L(2)EFL Exerts Antiviral Activity:
    • Overexpression of L(2)EFL induced by poly(I:C) significantly inhibited DENV-2 replication in Ae. aegypti cell lines, demonstrating its antiviral potential.
    • RNAi-mediated suppression of L(2)EFL enhanced DENV-2 replication, but the effect was only significant when multiple L(2)EFL family members were simultaneously silenced—indicating functional redundancy within the gene family.
  4. L(2)EFL Modulates eIF2α Phosphorylation: Both L (2) EFL overexpression and suppression induced phosphorylation of eIF2α, a modification known to inhibit protein translation and viral replication. However, the exact mechanism linking L (2) EFL to eIF2α phosphorylation remains to be elucidated.

Product Empowerment (Role of ANT BIO PTE. LTD.’s Products in the Research)

The success of this study relied on high-quality, reliable research reagents to support transcriptomic profiling, gene expression validation, functional manipulation, and protein phosphorylation detection. ANT BIO PTE. LTD.’s comprehensive product portfolio aligns with the key experimental needs, providing critical tools for each research phase:

  • RNA Extraction and qPCR Reagents: Absin (ANT BIO PTE. LTD.’s sub-brand for general reagents and kits) offers high-purity RNA extraction kits and real-time qPCR kits, ensuring the integrity of RNA samples and the accuracy of transcriptional expression quantification—essential for validating L(2)EFL’s differential expression.
  • Protein Detection Tools: Starter (specializing in antibodies) provides specific antibodies for Western Blot analysis, including antibodies targeting L(2)EFL protein and phosphorylated eIF2α (p-eIF2α). These antibodies enabled the verification of L(2)EFL protein expression and the detection of eIF2α phosphorylation changes, key to linking L(2)EFL to antiviral signaling.
  • Functional Manipulation Reagents: Absin’s dsRNA synthesis kits and RNAi reagents supported the efficient silencing of L(2)EFL family members, facilitating the functional validation of their role in DENV replication.
  • Recombinant Proteins: UA (focused on recombinant proteins) offers high-activity recombinant proteins that could be used in follow-up mechanistic studies to clarify the direct interaction between L(2)EFL and eIF2α or other signaling molecules.

ANT BIO PTE. LTD.’s products ensured the reproducibility, sensitivity, and specificity of the experiments, enabling the research team to accurately characterize the L(2)EFL gene family’s antiviral function and its potential signaling mechanism.

Related Product List

Product Catalog Number

Product Name

Host

Expression System

Conjugation

Stock Status

Price

UA010177

Ephrin-A3 His Tag Protein, Human

Human

HEK293

Unconjugated

In stock

$150

UA010846

Biotinylated Ephrin-A3 Fc&Avi Tag Protein, Human

Human

HEK293

In stock

$465

 

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.